2023
DOI: 10.1016/j.gene.2022.146961
|View full text |Cite
|
Sign up to set email alerts
|

Screening and identification of CNIH4 gene associated with cell proliferation in gastric cancer based on a large-scale CRISPR-Cas9 screening database DepMap

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
11
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 7 publications
(11 citation statements)
references
References 37 publications
0
11
0
Order By: Relevance
“…A relevant study confirmed that CNIH4 increased the metastatic activity in patients with colon cancer by forming a positive feedback loop involving TMED9, GLI1, and TGFα 7 . Furthermore, knockdown of CNIH4 suppressed the proliferation of gastric cancer cells 9 . However, the clinical applications and functional studies of CNIH4 in glioma are still limited.…”
Section: Discussionmentioning
confidence: 90%
See 1 more Smart Citation
“…A relevant study confirmed that CNIH4 increased the metastatic activity in patients with colon cancer by forming a positive feedback loop involving TMED9, GLI1, and TGFα 7 . Furthermore, knockdown of CNIH4 suppressed the proliferation of gastric cancer cells 9 . However, the clinical applications and functional studies of CNIH4 in glioma are still limited.…”
Section: Discussionmentioning
confidence: 90%
“…Researches indicated that CNIH4 potentially increases colon cancer cell metastatic activity by forming a positive feedback loop with TMED9, GLI1, and TGFα 7 . Besides, higher CNIH4 activity predicted poor prognosis in several human malignancies in recent investigations 7–9 . However, the therapeutic application and molecular processes of CNIH4 in glioma have not been fully discussed so far.…”
Section: Introductionmentioning
confidence: 99%
“…Usually, a multi-gene predictor is more accurate than a single-gene predictor as the prognostic ability of a single gene is limited. A predictor optimally constructed from the selected genes becomes a useful biomarker for predicting survival in breast cancer [ 10 , 11 , 12 , 13 , 14 , 15 ], lung cancer [ 6 , 7 , 8 , 9 , 16 , 17 ], gastric cancer [ 18 , 19 ], ovarian cancer [ 20 , 21 , 22 , 23 , 24 ], skin cancer [ 25 ], liver cancer [ 26 , 27 ], bladder cancer [ 28 ], head and neck cancer [ 29 , 30 ], glioma [ 31 ], myeloproliferative neoplasms [ 32 ], kidney cancer [ 33 ], and cancers of mixed types [ 34 , 35 ]. These analyses were performed mostly based on univariate Cox regression with the significance scaling of p -values, such as 0.05, 0.01, and 0.001, followed by cross-validation and/or external validation.…”
Section: Introductionmentioning
confidence: 99%
“…Among leukemia patients, 59.04% were male and 40.96% were female. With the continuous development and progress in science and technology and medical technology, cancer treatment methods, such as surgery, chemotherapy and cell-based therapy, have made great progress [ 8 , 9 , 10 ]. However, due to the complex pathogenesis of cancer, it is very difficult to treat it.…”
Section: Introductionmentioning
confidence: 99%